Trademark Search in Canada

MISCELLANEOUS DESIGN

View On IC.GC.CA

REGISTERED

on 4 Oct 2024

TM5 Status

LIVE/REGISTRATION/Issued and Active

Your registration has been issued and is active. You can now use the TM5 mark.

Last Applicant/ Owned by

PFIZER INC.

66 Hudson Boulevard EastNew York, New York 10001-2192

Serial Number

2240328 filed on 16^th Feb 2023

Registration Number

TMA1261498 registered on 4^th Oct 2024

Registration expiry Date

4^th Oct 2034

Correspondent Address

TORYS LLP

SUITE 300079 WELLINGTON ST. W.BOX 270, TD CENTRETORONTO

ONTARIO

M5K1N2

MISCELLANEOUS DESIGN

Trademark usage description

pharmaceutical preparations for the treatment of neurodegenerative, nerve, neuromuscular and brain diseases and disorders, namely muscular dystrophy a Read More

Vienna Information

26 . 1 . 1

CirclesCercles

26 . 1 . 6

Several circles or ellipses, juxtaposed, tangential or intersectingPlusieurs cercles ou ellipses, juxtaposés, tangents ou se coupant

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

26 . 7 . 4

Circles or ellipses with lines (except 26.7.3)Cercles ou ellipses avec lignes (excepté 26.7.3)

26 . 11 . 3

More than two lines or two bandsPlus de deux lignes ou de deux bandes

26 . 11 . 8

Horizontal lines or bandsLignes ou bandes horizontales

26 . 11 . 10

Straight lines or bandsLignes ou bandes droites

26 . 11 . 12

Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of neurodegenerative, nerve, neuromuscular and brain diseases and disorders, namely muscular dystrophy and ALS; Pharmaceutical preparations for the treatment of the central nervous system, namely brain diseases and central nervous system movement disorders; Pharmaceutical preparations for the treatment of cardiovascular, gastrointestinal and blood diseases and disorders; Pharmaceutical preparations for the treatment of auto-immune diseases and disorders, namely rheumatoid arthritis, lupus, alopecia, ulcerative colitis and Crohn's disease; Pharmaceutical preparations for the treatment of hypertension, menopause symptoms, obesity, stroke, arthritis, migraine, pain and endometriosis; Pharmaceutical preparations for the treatment of cancer; Anti-infectives, anti-inflammatories, anti-fungal and anti-viral agents; Pharmaceutical preparations for the treatment of kidney and liver diseases and disorders; Pharmaceutical preparations for the treatment of bone growth disorders; Pharmaceutical preparations for the treatment of diseases and disorders of the endocrine system, namely growth and thyroid disorders; Pharmaceutical preparations for the treatment of inflammatory diseases, namely inflammatory bowel diseases, inflammatory joint diseases, inflammatory connective tissue diseases, inflammatory muscle diseases and disorders; Pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely cachexia, diabetes, hypoglycemia, obesity, sickle cell disease, non-alcoholic steatohepatitis (NASH) and anemia; Pharmaceutical preparations for the treatment of skin and dermatological diseases and conditions, namely eczema, atopic dermatitis, psoriasis and vitiligo; Human vaccines

Classification kind code

Mark Details

Serial Number

2240328

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 190 on 4^th Oct 2024	Registration Pending
Submitted for opposition 42 on 17^th Jul 2024	Advertised
Submitted for opposition 27 on 24^th Jun 2024	Approval Notice Sent
Submitted for opposition 26 on 24^th Jun 2024	Approved
Submitted for opposition 22 on 14^th Jun 2024	Search Recorded
Submitted for opposition 135 on 30^th Jun 2023	Amendment to Application
Submitted for opposition 287 on 2^th Mar 2023	Pre-Assessment Letter Sent
Submitted for opposition 30 on 16^th Feb 2023	Filed
Submitted for opposition 1 on 16^th Feb 2023	Created
Submitted for opposition 31 on 16^th Feb 2023	Formalized